脳卒中管理市場レポート：タイプ、用途、エンドユーザー、地域別、2024～2032年

世界の脳卒中管理市場規模は2023年に357億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに617億米ドルに達し、2024～2032年の間に6.1％の成長率（CAGR）を示すと予測しています。医療システムにおける脳卒中の負担の増加、患者中心のケアと個別化された治療計画への注目の高まり、脳卒中管理技術の向上と新しい治療法の開発に向けた研究開発の活発化が、市場を後押しする要因のひとつです。

脳卒中管理には、脳への血流障害によって引き起こされる医療上の緊急事態である脳卒中の影響と長期的な影響を軽減するための包括的なアプローチが含まれます。効果的な脳卒中管理は、脳損傷を最小限に抑え、患者の転帰を改善し、生活の質を高めるために極めて重要です。脳卒中管理には、迅速かつ正確な診断が不可欠です。FAST頭字語（顔面下垂、腕の脱力、発話困難、救急隊を呼ぶまでの時間）などの迅速な評価ツールは、脳卒中の症状を特定し、タイムリーな医療介入を可能にするのに役立ちます。コンピューター断層撮影（CT）スキャンや磁気共鳴画像法（MRI）などの画像診断は、脳卒中のタイプと部位を特定するのに役立ちます。早急な治療は、脳への血流を回復させることに重点を置きます。虚血性脳卒中には、組織プラスミノーゲン活性化因子（tPA）などの血栓溶解薬や機械的血栓除去術が用いられます。出血性脳卒中では、出血を止め、脳への圧迫を和らげるために外科的治療が必要になることがあります。脳卒中後の管理には、失われた機能を回復し、障害を予防するためのリハビリテーションが含まれます。これには理学療法、作業療法、言語療法、心理的サポートなどが含まれます。また、高血圧、高コレステロール、血液希釈剤などの危険因子を管理するための薬が処方されることもあります。さらに、脳卒中の再発リスクを減らすためには、予防対策が不可欠です。健康的な食事、定期的な運動、禁煙、糖尿病や心房細動などの慢性疾患の管理といった生活習慣の改善は、脳卒中の管理にとって極めて重要です。脳卒中治療とリハビリテーションにおける継続的な調査と進歩は、脳卒中管理戦略と転帰を改善し続けています。

世界市場は主に脳卒中発症率の増加によって牽引されています。これに伴い、高齢化人口の増加が市場に大きく貢献しています。さらに、診断、画像診断、治療の選択肢における技術的進歩の高まりが、市場にプラスの影響を与えています。また、脳卒中の兆候や症状、迅速な管理の重要性に関する一般市民の意識の高まりも、市場を活性化しています。さらに、脳卒中の予防と管理に取り組む政府のキャンペーンやイニシアチブは、市場の拡大を促進しています。さらに、脳卒中管理の手順や治療に対する有利な償還政策は、医療プロバイダーのインセンティブとなり、市場を促進しています。さらに、遠隔医療技術や遠隔モニタリング技術の急速な普及により、脳卒中の遠隔管理が可能になり、市場の裾野が広がっています。脳卒中専用センターや専門施設の設立は、脳卒中管理能力を高め、市場を強化します。

脳卒中管理市場傾向/促進要因

慢性疾患の増加

慢性疾患の有病率の上昇が市場を促進しています。心血管疾患、糖尿病、高血圧などの慢性疾患は、脳卒中の主要な危険因子です。世界の人口が高齢化し、ライフスタイルがより座りっぱなしになるにつれて、こうした慢性疾患の有病率は増加の一途をたどっています。その結果、脳卒中を経験するリスクのある人口が増加しています。慢性疾患の増加により、効果的な脳卒中管理戦略に対する需要が高まっています。医療プロバイダーや医療機関は、包括的な脳卒中予防プログラムを開発し、タイムリーで効率的な治療プロトコルを実施するよう求められています。さらに、脳卒中の発生や再発のリスクを最小限に抑えるために、慢性疾患の継続的なモニタリングや管理の必要性が高まっています。慢性疾患と脳卒中との関係についての認識を高めるため、公衆衛生の取り組み、教育キャンペーン、予防対策が実施されています。こうした取り組みは、早期発見、生活習慣の改善、治療レジメンの遵守を促進することを目的としており、最終的には脳卒中の負担を軽減し、脳卒中管理ソリューション市場を活性化させます。

早期診断と治療の利点に関する個人の意識の高まり

早期診断と早期治療の利点に関する個人の意識の高まりは、市場に明るい展望をもたらしています。脳卒中の徴候、症状、結果に関する一般的な知識が向上するにつれて、個人はより積極的にタイムリーな医療措置を求めるようになっています。認知度の向上により、脳卒中の症状をいち早く認識し、直ちに医療機関を受診することの重要性を理解することができるようになりました。突然のしびれや脱力感、話すことや理解することの困難さ、激しい頭痛などの症状を認識することで、個人は遅滞なく救急医療を受けるようになります。早期診断と迅速な治療は、脳卒中による影響を最小限に抑え、患者の転帰を改善する上で極めて重要です。脳卒中に対する認識が高まれば、患者は迅速に行動しやすくなり、より迅速な介入や、血栓溶解薬や機械的血栓除去術などの救命治療につながる可能性があります。認知度を高めるための取り組みには、公衆衛生キャンペーン、教育的イニシアティブ、地域社会へのアウトリーチプログラムなどがあります。これらの努力は、脳卒中の予防、危険因子、即時の医療介入の必要性について個人を教育することを目的としています。認知度を高めることで、個人が積極的な対策を講じるようになり、脳卒中管理ソリューションの市場が活性化し、脳卒中治療全体が改善されます。

新しく先進的な機器や薬剤の採用

新しく先進的な機器や薬剤の導入は、市場に多くの機会をもたらします。医療機器や医薬品における技術の進歩や継続的な技術革新は、脳卒中治療に革命をもたらし、患者の転帰を改善し、市場を活性化しています。高度な画像診断、神経インターベンション、ロボット支援システムなどの新しい機器は、脳卒中の診断と治療の精度と正確性を高めています。これらの機器により、医療プロバイダーは迅速かつ効果的に血栓を除去し、脳への血流を回復させ、脳損傷の程度を最小限に抑えることができます。さらに、革新的なリハビリ機器や支援技術は、脳卒中の回復とリハビリを支援します。また、新薬の開発や薬学的介入も市場を牽引する上で重要な役割を果たしています。血栓溶解薬、神経保護薬、抗血小板薬は、脳卒中の治療と予防を大幅に改善しました。これらの薬剤は、血栓を溶解し、脳細胞を保護し、危険因子を管理して脳卒中再発の可能性を低減することを目的としています。さらに、新しい機器や薬剤の導入は脳卒中管理のパラダイムシフトをもたらし、より正確な診断、低侵襲治療、標的治療を可能にしています。このような進歩は患者ケアを向上させ、医療プロバイダーやメーカーに新たな機会をもたらし、市場を後押ししています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の脳卒中管理市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 診断
  • 市場動向
  • 主要セグメント
    • コンピュータ断層撮影スキャン（CTスキャン）
    • 磁気共鳴画像（MRI）
    • 頸動脈超音波試験
    • 脳血管造影試験
    • 心電図試験
    • 心エコー試験
    • その他
  • 市場予測
• 治療
  • 市場動向
  • 主要セグメント
    • 組織プラスミノーゲン活性化因子
    • 抗凝固剤
    • 抗血小板薬
    • 降圧剤
  • 市場予測

第7章 市場内訳：用途別

• 虚血性脳卒中
• 出血性脳卒中
• その他

第8章 市場内訳：エンドユーザー別

• 病院
• 外来手術センター
• 診断センター
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • Cardinal Health
  • General Electric Company
  • GlaxoSmithKline plc
  • Medtronic plc
  • Merck & Co. Inc.
  • Siemens Healthineers AG（Siemens AG）

List of Figures

• Figure 1: Global: Stroke Management Market: Major Drivers and Challenges
• Figure 2: Global: Stroke Management Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Stroke Management Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Stroke Management Market: Breakup by Type (in %), 2023
• Figure 5: Global: Stroke Management Market: Breakup by Application (in %), 2023
• Figure 6: Global: Stroke Management Market: Breakup by End User (in %), 2023
• Figure 7: Global: Stroke Management Market: Breakup by Region (in %), 2023
• Figure 8: Global: Stroke Management (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Stroke Management (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Stroke Management (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Stroke Management (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Stroke Management (Ischemic Stroke) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Stroke Management (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Stroke Management (Haemorrhagic Stroke) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Stroke Management (Haemorrhagic Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Stroke Management (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Stroke Management (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Stroke Management (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Stroke Management (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Stroke Management (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Stroke Management (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Stroke Management (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Stroke Management (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: Global: Stroke Management (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: Global: Stroke Management (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: North America: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: North America: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: United States: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: United States: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Canada: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Canada: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Asia-Pacific: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Asia-Pacific: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: China: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: China: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: Japan: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: Japan: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: India: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: India: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: South Korea: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: South Korea: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Australia: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Australia: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Indonesia: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Indonesia: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Others: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Europe: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Europe: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: Germany: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: Germany: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: France: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: France: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: United Kingdom: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: United Kingdom: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Italy: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Italy: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Spain: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Spain: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Russia: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Russia: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Others: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Latin America: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Latin America: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Brazil: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Brazil: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Mexico: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Mexico: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Others: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 72: Middle East and Africa: Stroke Management Market: Sales Value (in Million US$), 2018 & 2023
• Figure 73: Middle East and Africa: Stroke Management Market: Breakup by Country (in %), 2023
• Figure 74: Middle East and Africa: Stroke Management Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 75: Global: Stroke Management Industry: SWOT Analysis
• Figure 76: Global: Stroke Management Industry: Value Chain Analysis
• Figure 77: Global: Stroke Management Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Stroke Management Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Stroke Management Market Forecast: Breakup by Type (in Million US$), 2024-2032
• Table 3: Global: Stroke Management Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Stroke Management Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 5: Global: Stroke Management Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Stroke Management Market: Competitive Structure
• Table 7: Global: Stroke Management Market: Key Players

The global stroke management market size reached US$ 35.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 61.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The rising burden of strokes on healthcare systems, the increasing focus on patient-centered care and personalized treatment plans, and the growing research and development efforts to improve stroke management techniques and develop new therapies are some of the factors propelling the market.

Stroke management involves a comprehensive approach to reduce the impact and long-term consequences of stroke, a medical emergency caused by disrupted blood flow to the brain. Effective stroke management is crucial to minimize brain damage, improve patient outcomes, and enhance quality of life. Prompt and accurate diagnosis is essential in stroke management. Quick assessment tools, such as the FAST acronym (Facial drooping, Arm weakness, Speech difficulties, Time to call emergency services), aid in identifying stroke symptoms and enabling timely medical intervention. Diagnostic imaging, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), helps determine the type and location of the stroke. Immediate treatment focuses on restoring blood flow to the brain. Clot-dissolving medications like tissue plasminogen activator (tPA) or mechanical thrombectomy may be used for ischemic stroke. Hemorrhagic stroke may require surgical interventions to stop bleeding and relieve pressure on the brain. Post-stroke management involves rehabilitation to restore lost functions and prevent disability. This may include physical therapy, occupational therapy, speech therapy, and psychological support. Medications to manage risk factors like high blood pressure, high cholesterol, and blood thinners may also be prescribed. Additionally, preventive measures are essential to reduce the risk of recurrent strokes. Lifestyle modifications such as a healthy diet, regular exercise, smoking cessation, and managing chronic conditions, such as diabetes or atrial fibrillation, are crucial to stroke management. Ongoing research and advancements in stroke treatment and rehabilitation continue to improve stroke management strategies and outcomes.

The global market is primarily driven by the growing incidence of strokes. In line with this, the increasing aging population is significantly contributing to the market. Furthermore, the rising technological advancements in diagnostics, imaging, and treatment options are positively influencing the market. The growing public awareness about the signs, symptoms, and importance of prompt stroke management is also catalyzing the market. Moreover, the government's campaigns and initiatives to address stroke prevention and management promote market expansion. Besides, the favorable reimbursement policies for stroke management procedures and treatments incentivize healthcare providers and propel the market. Additionally, the rapid adoption of telemedicine and remote monitoring technologies allows for remote stroke management and expands the market reach. The establishment of dedicated stroke centers and specialized facilities enhances stroke management capabilities and strengthens the market.

Stroke Management Market Trends/Drivers:

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases is fostering the market. Chronic diseases, such as cardiovascular diseases, diabetes, and hypertension, are major stroke risk factors. As the global population ages and lifestyles become more sedentary, the prevalence of these chronic conditions continues to increase. This results in a larger population at risk of experiencing strokes. The increasing prevalence of chronic diseases creates a greater demand for effective stroke management strategies. Healthcare providers and organizations are prompted to develop comprehensive stroke prevention programs and implement timely and efficient treatment protocols. Additionally, there is a growing need for ongoing monitoring and management of chronic conditions to minimize the risk of stroke occurrence or recurrence. Public health initiatives, education campaigns, and preventive measures are being implemented to raise awareness about the relationship between chronic diseases and strokes. These efforts aim to promote early detection, lifestyle modifications, and adherence to treatment regimens, ultimately reducing the burden of strokes and fueling the market for stroke management solutions.

Rising awareness among individuals regarding the benefits of early diagnosis and treatments

Rising awareness among individuals about the benefits of early diagnosis and treatments is creating a positive outlook for the market. As public knowledge about the signs, symptoms, and consequences of strokes improves, individuals are becoming more proactive in seeking timely medical attention. Increased awareness empowers individuals to recognize stroke symptoms promptly and understand the importance of seeking immediate medical help. Recognizing symptoms such as sudden numbness or weakness, difficulty speaking or understanding, and severe headache prompts individuals to seek emergency care without delay. Early diagnosis and prompt treatment are critical in minimizing the impact of strokes and improving patient outcomes. With greater awareness, individuals are more likely to act swiftly, leading to faster intervention and potentially life-saving treatments such as clot-dissolving medications or mechanical thrombectomy. Efforts to raise awareness include public health campaigns, educational initiatives, and community outreach programs. These endeavors aim to educate individuals about stroke prevention, risk factors, and the need for immediate medical intervention. By increasing awareness, individuals are empowered to take proactive measures, bolstering the market for stroke management solutions and improving overall stroke care.

Introduction of new and advanced devices and drugs

Introducing new and advanced devices and drugs offers numerous opportunities for the market. Technological advancements and continuous innovation in medical devices and pharmaceuticals have revolutionized stroke care, improving patient outcomes and catalyzing the market. New devices, such as advanced imaging, neuro-interventional, and robotic-assisted systems, have enhanced the accuracy and precision of stroke diagnosis and treatment. These devices enable healthcare providers to swiftly and effectively remove clots, restore blood flow to the brain, and minimize the extent of brain damage. Additionally, innovative rehabilitation devices and assistive technologies aid in stroke recovery and rehabilitation. The development of new drugs and pharmaceutical interventions has also played a vital role in driving the market. Thrombolytic drugs, neuroprotective agents, and antiplatelet medications have significantly improved stroke treatment and prevention. These drugs aim to dissolve clots, protect brain cells, and manage risk factors to reduce the likelihood of recurrent strokes. Moreover, introducing new devices and drugs has led to a paradigm shift in stroke management, enabling more precise diagnoses, minimally invasive treatments, and targeted therapies. These advancements enhance patient care and create new opportunities for healthcare providers and manufacturers, propelling the market.

Stroke Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global stroke management market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Diagnostics

Computed Tomography Scan (CT Scan)

Magnetic Resonance Imaging (MRI)

Carotid Ultrasound

Cerebral Angiography

Electrocardiography

Echocardiography

Others

Therapeutics

Tissue Plasminogen Activator

Anticoagulant

Antiplatelet

Antihypertensive

Diagnostics dominate the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes diagnostics (computed tomography scan (CT Scan), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, others) and therapeutics (tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive). According to the report, diagnostics represented the largest segment.

Diagnostics are crucial in accurately identifying and assessing strokes, enabling timely and effective treatment decisions. CT scans and MRIs are key diagnostic tools used to evaluate stroke patients. CT scans provide rapid imaging to detect bleeding or blockages in blood vessels, helping determine the type and location of the stroke. MRIs, on the other hand, offer detailed brain imaging, assisting in identifying ischemic areas and aiding in treatment planning. The increasing prevalence of strokes and the emphasis on early detection and intervention drive the demand for diagnostic tools, such as CT scans and MRIs.

Technological advancements in CT and MRI imaging, such as higher resolution, faster scanning times, and improved imaging protocols, have enhanced the accuracy and efficiency of stroke diagnosis. The diagnostics segment's growth is further fuelled by integrating artificial intelligence (AI) algorithms into imaging systems, enabling automated analysis and interpretation of imaging data. This streamlines the diagnostic process, expedites treatment decisions, and improves patient outcomes.

Breakup by Application:

Ischemic Stroke

Haemorrhagic Stroke

Others

Ischemic Stroke holds the largest share of the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes ischemic stroke, haemorrhagic stroke, and others. According to the report, ischemic stroke accounted for the largest market share.

Ischemic stroke is the most common type, caused by the blockage or narrowing of blood vessels supplying the brain, leading to reduced blood flow and oxygen delivery. The focus on ischemic stroke management drives themarket growth as it accounts for a substantial portion of stroke cases. The increasing incidence of ischemic stroke, often associated with risk factors like hypertension, diabetes, and a sedentary lifestyle, demands effective management strategies.

Advancements in ischemic stroke management, such as the development of thrombolytic drugs like tissue plasminogen activator (tPA) and mechanical thrombectomy procedures, have revolutionized treatment options. These interventions aim to restore blood flow to the affected area, minimize brain damage, and improve patient outcomes. The emphasis on ischemic stroke management is further supported by public health initiatives promoting stroke prevention, early recognition of symptoms, and rapid intervention. These initiatives propel the market by increasing awareness, encouraging individuals to seek medical help promptly, and implementing evidence-based management approaches.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Others

Hospitals holds the largest share of the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgical centers, diagnostic centers, and others. According to the report, hospitals accounted for the largest market share.

Hospitals play a critical role in stroke care, as they are the primary healthcare facilities for acute stroke treatment, specialized diagnostics, and rehabilitation services. The demand for stroke management solutions is propelled by hospitals' need to provide patients with comprehensive and specialized stroke care. As the burden of strokes rises, hospitals strive to enhance their capabilities in stroke diagnosis, treatment, and rehabilitation, impacting the market positively.

Hospitals invest in advanced imaging systems, neuro-interventional devices, and rehabilitation technologies to deliver optimal stroke care. They collaborate with stroke management companies and engage in clinical research to implement evidence-based practices and offer the latest treatment options. Furthermore, hospitals serve as centers for stroke education and training, disseminating knowledge to healthcare professionals regarding stroke prevention, early recognition, and appropriate management. This contributes to improved patient outcomes and raises awareness among the healthcare community, propelling the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America is a key market for stroke management due to several factors contributing to its growth and development. The region has a high prevalence of stroke cases, making it a significant market for stroke management solutions. The region's aging population, sedentary lifestyles, and high incidence of risk factors such as hypertension and obesity contribute to the increased burden of strokes. Furthermore, the region boasts advanced healthcare infrastructure and robust research and development capabilities. This enables the region to lead in developing and adopting innovative stroke management technologies, diagnostic tools, and treatment modalities.

Moreover, North America has a well-established healthcare system and reimbursement structure that supports the adoption of stroke management solutions. Favorable reimbursement policies and insurance coverage for stroke-related interventions and treatments drive the market. The presence of leading stroke management companies, healthcare providers, and research institutions in North America fosters collaboration, research, and advancements in stroke management practices. This contributes to the market growth by continually improving treatment outcomes and driving the adoption of new technologies and techniques.

Competitive Landscape:

Top stroke management companies are strengthening the market through their expertise, innovation, and commitment to improving patient outcomes. These companies invest heavily in research and development to develop cutting-edge technologies, devices, and pharmaceuticals for effective stroke prevention, diagnosis, treatment, and rehabilitation. Leading stroke management companies actively collaborate with healthcare providers, research institutions, and industry experts to drive innovation and stay at the forefront of stroke care. They conduct clinical trials and studies to gather evidence-based data and continuously improve their products and services. These companies are also crucial in raising awareness about stroke prevention and early intervention. They engage in educational initiatives, public health campaigns, and partnerships with patient advocacy groups to promote stroke awareness and provide resources to healthcare professionals and the general public. Moreover, top stroke management companies focus on delivering comprehensive solutions that encompass diagnostics, acute care, rehabilitation, and ongoing management. By offering integrated and patient-centric approaches, they strive to optimize patient outcomes and improve quality of life through their commitment to advancing stroke management practices.

The report has provided a comprehensive analysis of the competitive landscape in the stroke management market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

B. Braun Melsungen AG

Boston Scientific Corporation

Bristol-Myers Squibb Company

Cardinal Health

General Electric Company

GlaxoSmithKline plc

Medtronic plc

Merck & Co. Inc.

Siemens Healthineers AG (Siemens AG).

Recent Developments:

In 2019, Abbott launched the Alinity m diagnostics system, a compact molecular testing platform designed to deliver fast and accurate results for infectious diseases like HIV, hepatitis, and more.

In 2019, B. Braun announced a collaboration with GuardRFID Solutions to enhance the company's asset tracking and management capabilities, improving efficiency in healthcare environments.

In 2019, Boston Scientific received FDA approval for the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device, a minimally invasive implantable device for reducing the risk of stroke in patients with non-valvular atrial fibrillation.

Key Questions Answered in This Report:

• How has the global stroke management market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global stroke management market?
• What is the impact of each driver, restraint, and opportunity on the global stroke management market?
• What are the key regional markets?
• Which countries represent the most attractive stroke management market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the global stroke management market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the global stroke management market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the global stroke management market?
• What is the competitive structure of the global stroke management market?
• Who are the key players/companies in the global stroke management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Stroke Management Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Diagnostics
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Computed Tomography Scan (CT Scan)
    • 6.1.2.2 Magnetic Resonance Imaging (MRI)
    • 6.1.2.3 Carotid Ultrasound
    • 6.1.2.4 Cerebral Angiography
    • 6.1.2.5 Electrocardiography
    • 6.1.2.6 Echocardiography
    • 6.1.2.7 Others
  • 6.1.3 Market Forecast
• 6.2 Therapeutics
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Tissue Plasminogen Activator
    • 6.2.2.2 Anticoagulant
    • 6.2.2.3 Antiplatelet
    • 6.2.2.4 Antihypertensive
  • 6.2.3 Market Forecast

7 Market Breakup by Application

• 7.1 Ischemic Stroke
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Haemorrhagic Stroke
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Diagnostic Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Abbott Laboratories
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 B. Braun Melsungen AG
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 Boston Scientific Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Bristol-Myers Squibb Company
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Cardinal Health
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 General Electric Company
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 GlaxoSmithKline plc
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Medtronic plc
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Merck & Co. Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Siemens Healthineers AG (Siemens AG)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis